Company: SCYX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001140361-25-016641
Chunk: 35

Company: SCYNEXIS INC
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 35
---
 by our Compensation Committee without members of management present. The compensation of our Chief Executive Officer is now determined and approved by our Board of Directors without members of management present, based on recommendations from our Compensation Committee. The 2024 annual base salaries for our named executive officers are set forth in the table below.

| Name                  |     | 2024 Base Salary 
              ($) |
| David Angulo, M.D.(1) |     |          601,000 |
| Ivor Macleod(2)       |     |          452,400 |
| Scott Sukenick(3)     |     |          445,120 |

| (1) | In January 2025, our Board of Directors increased Dr. Angulo’s annual salary to $631,050. |

| (2) | In January 2025, our Compensation Committee increased Mr. Macleod’s annual salary to $470,496. |

| (3) | In January 2025, our Compensation Committee increased Mr. Sukenick’s annual salary to $462,925. |

Annual Performance-Based Bonus Opportunity We seek to motivate and reward our executives for achievements relative to our corporate goals and expectations for each fiscal year. In 2024, each of our named executive officers was eligible to receive an annual performance bonus based on the achievement of performance goals as determined by our Board of Directors or an authorized committee thereof. Each named executive officer has a target bonus represented as a percentage of base salary (a “target bonus percentage”) each of which is set forth below:

| Name               |     | 2024 Target Bonus |
| David Angulo, M.D. |     | 55%               |
| Ivor Macleod       |     | 40%               |
| Scott Sukenick     |     | 40%               |

The annual corporate performance goals are generally tied to achievement of research and development, finance, and other milestones important to our business. The Compensation Committee and our Board of Directors reviews the Company’s achievement of the corporate goals in their totality, taking into account the Company’s overall performance for the year. The corporate goals established and achieved for 2024 included various research and development activities and objectives. The annual performance bonus for our Chief Executive Officer is tied entirely to the achievement of corporate goals which were achieved at 93% of target, resulting in an annual performance bonus of $307,412 for Dr. Angulo. For our other named executive officers, the annual performance bonus is determined based